Position
Fidelity in Acadia Pharmaceuticals Inc
Back to the book · All holders of ACAD
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $730.8K$22.26 → $25.30
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 727K | $19.4M | — | — | — | 0.0% |
| Q1 2026 | 350.3K | $7.8M | $22.26 | −$1.56M | −$10.1M | 0.0% |
| Q2 2026 | 240.4K | $6.08M | $25.30 | $730.8K | −$2.45M | 0.0% |